← All trials
NCT05032014
N/AInterventional
Trials without FDA-defined phases, including trials of devices or behavioral interventions.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 19, 2021
- Primary completion
- Dec 27, 2022
- Completion date
- Dec 30, 2023
- First posted
- Sep 2, 2021
- Last posted
- Oct 25, 2021
- Enrollment
- 46
- Arms / groups
- 3 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Jiangxi Provincial Cancer HospitalLead sponsor
- Jiangxi Provincial Cancer HospitalReponsible party - principal investigator
- Inner Mongolia Agricultural UniversityCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.